Back
Cingulate Vs. United Therapeutics Industry Stock Comparison
Sell
24
CING
Cingulate
Last Price:
4.63
Seasonality Move:
-44.46%
Sell
50
UTHR
United Therapeutics
Last Price:
366.97
Seasonality Move:
10.82%
Sell
24
Cingulate (CING)
is a Sell
Is Cingulate a Buy, Sell or Hold?
- The current Cingulate [CING] share price is $4.48. The Score for CING is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- CING is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $364.33. The Score for UTHR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CING Stock Price Chart
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $364.33
The current trend is moderately bearish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CING Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 53.1 | Buy |
| Chaikin Money Flow: | -179044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.78 - 4.66) | Buy |
| Bollinger Bands (100): | (2.83 - 7.55) | Sell |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 44.48 | Sell |
| Chaikin Money Flow: | 110184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (355.36 - 392.44) | Sell |
| Bollinger Bands (100): | (327.49 - 369.99) | Buy |
CING Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.25 | Buy |
| 20-day SMA: | 4.08 | Buy |
| 50-day SMA: | 4.61 | Sell |
| 200-day SMA: | 8.22 | Sell |
| 8-day EMA: | 4.18 | Buy |
| 20-day EMA: | 4.2 | Buy |
| 50-day EMA: | 4.72 | Sell |
| 200-day EMA: | 23.81 | Sell |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 379.48 | Sell |
| 20-day SMA: | 375.79 | Sell |
| 50-day SMA: | 363.31 | Buy |
| 200-day SMA: | 300.12 | Buy |
| 8-day EMA: | 373.36 | Sell |
| 20-day EMA: | 374.93 | Sell |
| 50-day EMA: | 364.61 | Sell |
| 200-day EMA: | 314.85 | Buy |
Cingulate Earnings Growth & CING Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.68 per share, a decrease next quarter of $0.00 per share, an increase this year of $315.94 per share, and an increase next year of $5.20 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
Cingulate Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||